Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

STRATA Skin Sciences (SSKN) FCF Margin (2016 - 2025)

STRATA Skin Sciences' FCF Margin history spans 14 years, with the latest figure at 17.32% for Q4 2025.

  • On a quarterly basis, FCF Margin fell 757.0% to 17.32% in Q4 2025 year-over-year; TTM through Dec 2025 was 13.88%, a 957.0% decrease, with the full-year FY2025 number at 13.88%, down 957.0% from a year prior.
  • FCF Margin hit 17.32% in Q4 2025 for STRATA Skin Sciences, down from 0.35% in the prior quarter.
  • Over the last five years, FCF Margin for SSKN hit a ceiling of 8.73% in Q3 2024 and a floor of 34.48% in Q1 2023.
  • Historically, FCF Margin has averaged 11.18% across 5 years, with a median of 9.91% in 2021.
  • Biggest five-year swings in FCF Margin: surged 2936bps in 2024 and later tumbled -2745bps in 2025.
  • Tracing SSKN's FCF Margin over 5 years: stood at 5.09% in 2021, then crashed by -182bps to 14.34% in 2022, then soared by 72bps to 3.99% in 2023, then plummeted by -144bps to 9.74% in 2024, then tumbled by -78bps to 17.32% in 2025.
  • Business Quant data shows FCF Margin for SSKN at 17.32% in Q4 2025, 0.35% in Q3 2025, and 24.53% in Q2 2025.